Drug Approval | June 07, 2022
Zydus Lifesciences receives USFDA approval for Adapalene and Benzoyl Peroxide Topical Gel
The drug will be manufactured at the group’s topical facility at Ahmedabad
The drug will be manufactured at the group’s topical facility at Ahmedabad
A research group led by Ben-Gurion University of the Negev managed to produce an innovative microchip for creating sperm in a culture by using a microfluidic system.
Innate to receive $5M milestone payment from AstraZeneca
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
The abstract is about the cohort A, stage I of the ongoing global phase ? trial that evaluating the safety and efficacy of Catumaxomab in advanced GC patients with peritoneal metastasis
Researchers found that the drug combination led to a sustained and tenfold increase in the production of CD8 T cells and natural killer cells
Pemetrexed for Injection has a market size of USD 1,236 mn (as per IQVIA MAT March’22)
If approved, ABBV-951 will offer patients the first continuous subcutaneous delivery of carbidopa/levodopa prodrugs
PRP is a mixture of two proenzymes, trypsinogen and chymotrypsinogen from bovine pancreas administered by intravenous injection
Phase I trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for safety and immunogenicity and strengthen regional scientific capacity
Subscribe To Our Newsletter & Stay Updated
